Sun Pharma shares in focus after US launch of LEQSELVITM, Incyte settlement Posted by Able on July 14, 2025 Get link Facebook X Pinterest Email Other Apps Sun Pharma shares will be in focus on July 15 after the company announced the US launch of LEQSELVITM (deuruxolitinib) for severe alopecia areata and a settlement agreement with Incyte Corporation related to the same drug. Comments
Comments
Post a Comment